Nuveen Churchill Private Capital Income Fund完成要约收购，支付2,284.3万美元

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE TO

(Rule 13e-4)

TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Nuveen Churchill Private Capital Income Fund

(Name of Issuer)

Nuveen Churchill Private Capital Income Fund

(Name of Person(s) Filing Statement)

Class I, Class D, and Class S Shares of Beneficial Interest (Title of Class of Securities)

67114U 105, 67114U 303, and 67114U 204

(CUSIP Number of class of securities)

John D. McCally, Esq.

General Counsel

Churchill Asset Management LLC

8500 Andrew Carnegie Blvd

Charlotte, NC 28262

(212) 478-9200

(Name, Address and Telephone No. of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing Statement)

With a copy to:

Steven B. Boehm, Esq.

Payam Siadatpour, Esq.

Owen J. Pinkerton, Esq.

Sara Sabour Nasseri, Esq.

Eversheds Sutherland (US) LLP

700 6th Street, N.W.

Washington, DC 20001

August 28, 2026

(Date Tender Offer First Published, Sent or Given to Security Holders)

FINAL AMENDMENT TO TENDER OFFER STATEMENT

This Amendment No. 1 amends and supplements the Tender Offer Statement on Schedule TO (the “Statement”) originally filed with the Securities and Exchange Commission on August 28, 2026 by Nuveen Churchill Private Capital Income Fund (the “Fund”) in connection with the offer by the Fund (the “Offer”) to purchase up to 3,091,920 of its outstanding common shares of beneficial interest (including Class I common shares of beneficial interest (“Class I Shares”), Class S common shares of beneficial interest (“Class S Shares”), and Class D common shares of beneficial interest (“Class D Shares” and together with Class I Shares and Class S Shares, the “Shares”)), at a price equal to the net asset value per applicable class of Share as of September 30, 2026 (the “Valuation Date”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August 28, 2026, and the related Letter of Transmittal, filed as Exhibits (a)(1)(ii)-(iii) to the Statement.

This is the Final Amendment to the Statement and is being filed to report the results of the Offer. The following information is furnished pursuant to Rule 13e-4(c)(4) under the Securities Exchange Act of 1934, as amended:

1.The Offer expired at 11:59 p.m., Eastern Time, on September 28, 2026.

2.836,944.98 Class I Shares, 16,226.14 Class D Shares, and 106,054.45 Class S Shares were validly tendered prior to the expiration of the Offer. The Fund accepted for purchase 100% of the Class I Shares, Class D Shares, and Class S Shares that were validly tendered and not withdrawn prior to the expiration of the Offer as permitted by Rule 13e-4(f)(1) of the Securities Exchange Act of 1934, as amended.

3.The net asset value of Class I Shares, Class D Shares, and Class S Shares tendered pursuant to the Offer was calculated as of the Valuation Date in the amount of $23.83, $23.83 and $23.75, respectively.

4.The payment of the purchase price of Class I Shares, Class D Shares, and Class S Shares tendered was made in the form of non-interest bearing, non-transferable promissory notes issued to the shareholders whose tenders were accepted for purchase by the Fund in accordance with the terms of the Offer. Pursuant to the promissory notes, the Fund paid on or about October 29, 2026 to the tendering shareholders a total of $22,843,227 representing the net asset value of the total amount of Class I Shares, Class D Shares, and Class S Shares tendered by shareholders, less the early repurchase deduction, as applicable. Class I Shares, Class D Shares, and Class S Shares were repurchased at a price of $23.83 per share, $23.83 per share, and $23.75 per share, respectively, as of the Valuation Date.

Except as specifically provided herein, the information contained in the Statement, as amended, and the Letter of Transmittal remains unchanged and this Amendment does not modify any of the information previously reported on the Statement, as amended, or the Transmittal Letter.

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

EXHIBIT INDEX